Potentiating Doxorubicin Activity Through BCL-2 Inhibition in P53 Wild-Type and Mutated Triple-Negative Breast Cancer

Anna R Schreiber, Stephen G Smoots, Marilyn M Jackson, Stacey M Bagby, Evan D Dus, Adrian T A Dominguez, Cameron A Binns,Todd M Pitts,Jennifer R Diamond

Frontiers in oncology（2025）

Cited 0|Views3

Key words

senescence,doxorubicin,TNBC,venetoclax,resistance

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined